Sign in

Research summary ·

An Updated Algorithm for the Management of Restless Legs Syndrome.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This paper is a guide for doctors who treat restless legs syndrome (RLS). Primary care doctors look after much of RLS care. An expert board from the RLS Foundation wrote it. They looked at studies published since 2020. They also drew on the shared views of experts. It updates an earlier version from 2021.

What they found

The guide gives step-by-step advice on treating RLS today. For RLS that comes and goes, it covers ways based on behavior. It lists new reasons to give iron by mouth or into a vein. It notes that some drugs can make RLS worse. It also covers how to handle dopamine agonist augmentation. Newer options it covers include peroneal nerve stimulation and buprenorphine.

What it means for patients

The guide says doctors can use gabapentinoids as the first drugs for lasting RLS. It warns that dopamine agonists carry risks and need care if used. It says low-dose opioids have an important role when used safely. It also covers RLS in children and during pregnancy and breastfeeding. It covers people with end-stage kidney failure and people around the time of surgery.

Why it is not certain yet

The guide rests partly on expert opinion, not only on study results. The abstract does not say how strong the evidence is for each step. Some approaches it mentions are still being studied or are for the future. A guide can only be as good as the studies behind it.

Source

An Updated Algorithm for the Management of Restless Legs Syndrome.

PubMed · PMID 42203073

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Restless legs syndrome publications